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Abstract
Introduction: Rheumatic diseases are among the most common and debilitating health problems in the United
States. These diseases are chronic, can result in severe decrements of physical and psychosocial functioning and
affect patients’ overall quality of life. A consensus regarding the best patient outcomes to be measured in
randomized, controlled trials and prospective natural history studies is essential to provide best estimates of
efficacy and safety of interventions across diverse patient populations.
Methods: Face-to-face English- and Spanish-language cognitive interviews were conducted among urban Hispanic
and African American patients with rheumatic disease to develop a questionnaire booklet. Six measures validating
patient-reported outcomes were included: the Arthritis Self-Efficacy Scale, the Stanford Health Assessment
Questionnaire Disability Index, the Wong-Baker Faces Pain Scale, the Short Acculturation Scale, the Center for
Epidemiologic Studies Depression Scale and the Inventory of Complementary and Alternative Medicine Practices.
A sample of patients (n = 15) attending the National Institute of Arthritis and Musculoskeletal and Skin Diseases
Community Health Center participated in the initial interviews. Revised measures were further tested for reliability
in a separate sample of patients (n = 109) upon enrollment at the health center.
Results: Cognitive interviews provided feedback for questionnaire modifications and methods to enhance content
validity and data quality, including discarding redundant questions, providing visual aids and concrete examples
when appropriate and increasing the use of racially and ethnically concordant interviewers. The cognitive
interviews further elucidated that some contextual assumptions and language usage in the original questionnaires
may not have taken each respondent’s environmental and sociocultural context into consideration. Internal
reliability for previously tested measures remained high (Cronbach’s a = 0.87-0.94).
Conclusions: Cognitive interviewing techniques are useful in a diverse sample of racial and ethnic minority
patients with rheumatic disease as a method to assess the content validity of the specific outcome measures
selected. The data collection approaches and methods described here ultimately enhance data quality. Vigilance is
required in the selection of outcome measures in studies or in practice, particularly with each new language
translation and/or culturally unique or diverse sample.
Introduction
Rheumatic diseases are among the most common and
debilitating health problems in the United States. Arthri-
tis is the most common cause of disability in the United
States, with approximately 19 million adults reporting
activity limitations related to their arthritis [1]. These
diseases are chronic and can result in severe decrements
of physical and psychosocial functioning affecting
patients’ overall quality of life. Among the effects are
impairments in activities of daily living, occupational
and social functioning and cognitive ability [2]. Interdis-
ciplinary teams that integrate specialty care in rheuma-
tology with a focus on rehabilitation must agree on
o u t c o m em e a s u r e st h a th a v eal e v e lo fs e n s i t i v i t ya n d
specificity to measure changes in their patients over
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ure of inflammatory rheumatic diseases make it difficult
to reach consensus on selecting representative outcome
measures [3]. Comprehensive perspectives that include
best practices endorsed byt h eO u t c o m eM e a s u r e si n
Rheumatology group and the World Health Organiza-
tion’s International Classification of Functioning, Dis-
ability and Health provide guidelines for development
that can be applied to address outcome measurement in
a variety of clinical and research-intensive settings [4,5].
Consensus on the outcomes to be measured in rando-
mized, controlled trials and prospective natural history
studies is essential because utilizing common measures
across studies can provide best estimates for efficacy
and safety across diverse patient populations [6].
Patients’ perspectives of their disease are broad and
include the impact of the disease beyond disease pathol-
ogy and functional disability as measured by traditional
instruments. Patient-reported outcomes (PROs) allow
clinicians and researchers to map out an individual’s
experience of symptoms in detail and further explicate
the impact of specific rheumatic diseases from the
underlying mechanisms of t h ed i s e a s et ot h e i rb r o a d
psychosocial impact on individuals, their family and
their communities.
Computerized adaptive testing and item response the-
ory have led to the potential for shorter instruments
with increased precision, thus advancing the science of
outcome evaluations [7]. It is unclear, however, whether
PROs are suited to being used primarily for research
purposes or as part of an assessment during a clinical
encounter. Although PROs are playing an increasingly
important role in research related to racial and ethnic
health disparities, most existing self-report measures
have been developed in mainstream samples and have
not been demonstrated to be valid in ethnically and cul-
turally diverse populations [8].
One approach to validating the utility and relevance of
PRO measures in diverse populations is through cogni-
tive interviewing, which has increasingly been described
in the behavioral and public health literature as a signifi-
cant adjunct to traditional pilot testing, particularly in
diverse populations [2,9-12]. Cognitive interviewing pro-
vides investigators and clinicians with a methodology to
explore respondents’ abilities to interpret questions, the
techniques they use for retrieving information from
memory, judgment formation in answering specific
questions and editing responses [13,14]. Such insight is
especially relevant for cross-cultural research when mea-
sures developed for use in one culture are applied to
another one [10].
This paper describes the cognitive interviewing pro-
cess utilized by the investigators to refine a question-
naire designed to assess PROs and complementary and
alternative medicine (CAM) practices [15] among Hispa-
nic and African American patients with rheumatic dis-
ease. Specifically, the study was designed to 1) assess
whether the instruments selected for an outcomes study
in racial and ethnic minority patients with rheumatic
disease were understood as intended, 2) confirm that
the measures possessed content validity, 3) determine
whether there were any unforeseen inaccuracies in the
item translations and cultural conversions, 4) establish
whether the selected measures could be used in a
diverse urban sample, and 5) identify data collection
approaches or methods that might be used to enhance
data quality.
Materials and methods
Cognitive interviews were conducted during the pilot
testing phase of a descriptive study among underserved
patients with rheumatic disease. Validation through cog-
nitive interviews is crucial because although these stan-
dardized instruments have been successful in measuring
outcomes in diverse populations, their cultural and lin-
guistic relevance may change over time and with each
new population. The cognitive interviews were used to
test the reliability and validity of six instruments with an
African American and predominantly first-generation
Hispanic sample population. Despite the fact that Span-
ish-language measures of pain, functional status, self-
efficacy and mood in patients with rheumatic disease
have previously been tested in other Hispanic commu-
nities, they were included in this cognitive interviewing
process to validate their use in respondents from Cen-
tral and South America and the Caribbean, as well as in
African Americans, in this underserved community
[16-19].
Setting and sample
Participants were recruitedf r o mac o n v e n i e n c es a m p l e
of patients attending the Community Health Center
(CHC) and enrolled in the intramural National Institute
of Arthritis and Musculoskeletal and Skin Diseases
(NIAMS) Natural History of Rheumatic Disease in Min-
ority Communities protocol (01-AR-0227). The NIAMS
Community Health Center is located in the heart of a
multicultural community in northwest Washington, DC,
USA. The CHC is situated in the Upper Cardozo Clinic
operated by Unity Health Care, Inc., a community-based
health management company providing health care to
uninsured and underinsured Washington, DC, area resi-
dents. This study was approved by the NIAMS institu-
tional review board. Patients provided written informed
consent to participate in this study.
Cognitive interview participants (n = 15) were predo-
minantly female (n = 13), first-generation Hispanic (n =
10), and African American (n = 5), with a mean age
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countries of origin as the United States (n = 5), Puerto
Rico (n = 1), Guyana (n = 1), El Salvador (n = 4), Ecua-
dor (n =1 ) ,H o n d u r a s( n =2 )a n dN i c a r a g u a( n =1 ) .
The country of origin for Hispanic participants is signifi-
cant for this study because according to the 2007 Amer-
ican Communities Survey [20], the majority of Hispanics
in the United States were from Mexico (64%) and only
8% are from Central America. However, for all three
districts (Maryland; Washington, DC; and Virginia,
USA) served by the NIAMS CHC, Central Americans
are the predominant Hispanic population group (ran-
ging from 33% to 44%). The instrument reliability test-
ing sample (n = 109) included patients newly enrolled at
the CHC who were predominantly female (n = 82), Afri-
can American (n = 40) and first-generation Hispanic
(n = 46) from Central America with a mean age (±SD)
of 51.3 ± 13.2.
Instruments
During the preliminary phase of designing an outcomes
evaluation for patients with rheumatic disease attending
the CHC, an interdisciplinary group of physicians,
nurses, health educators and nutritionists identified PRO
variables of interest in this population, including depres-
sion or mood, functional status, pain, self-efficacy, accul-
turation and CAM practices. The proposed outcomes
evaluation questionnaire for this exploratory study
included (1) the Short Acculturation Scale (SAS), (2) the
Stanford Health Assessment Questionnaire Disability
Index (HAQ-DI), (3) the Wong-Baker Faces Pain Scale,
(4) the Arthritis Self-Efficacy Scale (ASES), (5) the Cen-
ter for Epidemiologic Studies Depression Scale (CES-D)
(see Table 1), and (6) the Inventory of Complementary
and Alternative Medicine Practices (ICAMP).
Validating a measure to assess the use of CAM was of
particular interest in the sample because the interdisci-
plinary team suspected that there may be unreported use
of CAM among this diverse and underserved sample.
Patients with rheumatic disease may seek relief through
strategies considered CAM because of both the acute and
chronic nature of pain and symptoms, as well as the
accompanying decreases in physical function and health-
related quality of life. Despite improvements in the mea-
surement of PROs in patients with rheumatic disease,
there is no consensus regarding how best to ask about
these self-reported CAM beliefs and practices, whether
for research purposes or as an assessment during a clini-
cal encounter. Furthermore, little is known about the
applicability or utility of CAM measures across culturally
and linguistically diverse populations. It is still relatively
uncommon for patients with rheumatic disease to volun-
teer information about additional CAM treatments they
are using [21,22], and survey teams consistently identify
the need for health care providers to assess this informa-
tion on a routine basis. With permission from Dr. Leigh
Callahan at the Thurston Arthritis Research Center at
University of North Carolina, Chapel Hill, we began test-
ing a modified version of the Complementary and Alter-
native Medicine Use in Arthritis Questionnaire that was
p a r to fab a s e l i n eq u e s t i o n n a i r ef o rt h eC o n s o r t i u mf o r
the Longitudinal Evaluation of African Americans with
Early Rheumatoid Arthritis Registry [15]. The Arthritis
Foundation’s Guide to Alternative Therapies [23], along
with the work of Eisenberg et al. [24], were also used to
generate lists of potential CAM practices.
CAM use was determined by asking separately about
eight specific categories: (1) use of alternative health
providers or therapists; (2) special diets; (3) vitamins
and minerals; (4) herbs, mixtures or other supplements;
(5) rubs, lotions, liniments, creams and oils; (6) other
body treatments (that is, copper bracelets, paraffin, mag-
nets); (7) movement activities and (8) spiritual, relaxa-
tion and mind-body activities. An additional Health
Decisions section at the end of the questionnaire related
to CAM use was included to determine the respondents’
perceptions regarding their level of participation in
health decisions [14], the reason for using the type of
CAM they identified, whether they discussed CAM use
with their regular health care provider, how much
money they spent monthly on CAM and whether CAM
use changed their use of standard allopathic therapies.
The order of the measures presented to participants was
prioritized by the level of importance of the outcomes
measured. It was assumed ap r i o r ithat some respon-
dents would have too much pain and discomfort to sit
for extended periods of time for the interview. Because
pain and functional ability were two of the primary out-
comes of importance, they were listed first.
Interview procedures
One bilingual researcher conducted the cognitive inter-
views. A second bilingual researcher observed the inter-
views and tape-recorded and transcribed the responses.
Respondents were prepared for the cognitive interviews
using the following script with practice think-aloud
exercises:
“While we are going through the questionnaire, I’m
going to ask you to think aloud so that I can under-
stand if there are problems with the questionnaire.
By ‘think aloud’ I mean repeating all the questions
aloud and telling me what you are thinking as you
hear the questions and as you pick the answers.
Here is an example: Visualize the place where you
live and think about how many windows there are in
that place. When you are counting the windows tell
me what you are seeing and thinking.”
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￿ 8-item scale 1 (very uncertain) to 10 (very
certain)
1-10 ￿ The final 8-item scale had internal
reliability ranging from Cronbach’s a =
0.88 in the Cuban-origin group to
Cronbach’s a = 0.93 for the individuals of
Mexican and Central American descent
[16].
￿ The test-retest results revealed five items
with weak correlations of r < 0.40. The
items were found to have ambiguous
wording, were redundant, and thus were
removed from the scale.
￿ The proposed 8-item self-efficacy scale is
based on translation and validation studies
conducted in six geographic locations: five
in the United States and one in Latin
America [16].
Health Assessment Questionnaire Disability
Index (HAQ-DI)
￿ The 8-item scale measures areas of
patient function: dressing and grooming,
arising, reaching, gripping, eating, hygiene,
walking and errands and chores.
1-3 ￿ The test-retest reliability ranges from 0.87
to 0.96, with validity supported by a
number of studies [32].
￿ The HAQ-DI has undergone extensive
psychometric testing in diverse
populations, including Hispanics.
￿ Gonzalez et al. [16] conducted scaling,
replication and test-retest studies to
validate Spanish translations of the
instrument. Internal consistency as
measured by Cronbach’s a was good,
ranging from 0.87 to 0.89.
Wong-Baker Faces Pain Scale
￿ Consists of six cartoon faces ranging from
smiling face for “no pain” to tearful face for
“worst pain” [33]. The scale includes facial
expressions, numbers and words [34].
1-10 ￿ Use of traditional pain scales has received
mixed results in Hispanic populations.
Gonzalez et al. [16] found that when
comparing the Spanish version of the 0-10
Visual Analogue Pain Scale and Visual
Numeric Pain Scale, the correlation was r =
0.72.
￿ The frequency of missing data was 24%
for the Visual Analogue Scale and 6% for
the Visual Numeric Scale. An individual’s
familiarity with the format of an
instrument can influence the accuracy of
the response [11].
￿ Short Acculturation Scale (SAS)
Participants were asked to answer four
items each with a five-point scale.
￿ Each item was scored from 1 to 5. Scores
were summed to create an acculturation
scale ranging from 4 to 20. The higher the
combined score, the more acculturated the
respondent.
4-20 ￿ Norris et al. [25] found the shorter four-
item language subscale to be reliable, with
a Cronbach’s coefficient a of 0.80.
￿ Wallen et al. [26] further evaluated the
internal consistency of the SAS in a
predominantly Central American
population, with a Cronbach’s coefficient a
of 0.81.
Center for Epidemiologic Studies
Depression Scale (CES-D)
￿ CES-D 20-item scale was selected to
reflect the following six components:
depressed mood, feelings of guilt and
worthlessness, helplessness and
hopelessness, psychomotor retardation, loss
of appetite and sleep disturbance during
the past week.
Responses to each item ranged from 1
(rarely or none of the time) to 3 (most or
all of the time). Higher scores indicate a
higher degree of symptomatology.
0-60 ￿ Internal consistency of the measure has
been good. Split-half correlations were
reported as 0.85 for patient groups and
0.77 for normal groups.
￿ Cronbach’s coefficient a and Spearman-
Brown coefficients were 0.90 or above for
both volunteers and patients [35,36].
￿ The CES-D was validated in both
household surveys and psychiatric settings.
Test-retest reliability ranges have been
reported from 0.32 for 12 months to 0.67
for 4 weeks.
Spanish
￿ A translation of the CES-D by the
National Center for Health Statistics for the
Hispanic Health and Nutrition Examination
Survey (HHANES) was tested in both
scaling (n = 272) and replication (n = 151)
studies. The internal reliability for the 20-
item scale was high (Cronbach’s a = 0.90).
Spanish
￿ The Spanish version of the CES-D is
based on the translation and validation of
arthritis outcome measures published by
Gonzalez et al. [16].
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addition to the think-aloud method, spontaneous and
prepared verbal probes were designed to elicit feedback
about the suggested responses on the questionnaire.
The following are examples of the verbal probes used:
1) Paraphrase: Can you please repeat this question in
your own words?; 2) Comprehension probe: What does
the term “blues” mean to you? (referring to an item in
the CESD); 3) General probes: How did you arrive at
your answer? Are the questions hard or easy to answer?;
4) Recall probes: How do you remember what to
answer? Is it easy or difficult to remember what hap-
pened?; 5) Confidence judgment: How sure are you of
your answers?
Seven of the fifteen interviews were conducted in
Spanish, with the remainder conducted in English. Most
of the measures had previously been translated into
Spanish, including the CES-D [16], the Wong-Baker
Faces Pain Scale, the ASES [16] and the SAS [25,26].
Although most of the instruments had undergone exten-
sive psychometric testing, they had not been widely used
in these specific subpopulations (see Table 1). The
ICAMP had not previously been translated into Spanish,
and no reliability and validity data were available for the
ICAMP at the time of this study. After these cognitive
interviews were conducted, data using the original
ICAMP measure in patients with rheumatic disease
were published [15].
Translation
Translation is highlighted within the cognitive process
because of the impact of multiple dialects within the
Hispanic community, where a single word may have two
or more totally different meanings depending upon the
person’s country of origin. To translate a questionnaire
that was culturally and linguistically relevant for Spanish
speakers with varying countries of origin, collaboration
w a ss o u g h tf r o mH i s p a n i cp r o fessionals from Central
and South America as well as from the Caribbean.
These professionals’ expertise included Hispanic and
Latino culture, multicultural communications, clinical
research and research methods. Collaborators shared
knowledge and expertise, exchanged ideas and listened
to each other. The multiple perspectives allowed us
to anticipate problem areas and develop language
alternatives.
Decentering and reverse translation were the techni-
ques used in the translation process. Reverse translation
is a technique whereby the original questionnaire is
translated into another language and then translated
back into the source language by a blinded independent
translator. Decentering is another technique in which it
is possible to change the original English version of
an instrument during cross-culture review prior to
cognitive testing [10]. For example, for the HAQ-DI
translation, the suggestion was made prior to the initial
testing to use both mandados (errands) and compras
(shopping) to translate the concept of running errands
for this particular population. Special attention was paid
to comments from respondents related to cultural con-
text and language usage. Through probing during the
cognitive interviews, respondents provided suggestions
for wording that they found confusing to increase the
cultural relevance and respondents’ comprehension of
the final questionnaire.
Data analysis
As a preliminary step, information from individual field
notes and the interview guide with transcribed responses
became the basis for creating a cognitive interview sum-
mary for each participant. The purpose of the cognitive
interview summary was to recognize key aspects of each
interview and to begin to identify and capture develop-
ing patterns. The cognitive interview summary included
(1) interview duration, (2) language used during inter-
v i e wb a s e do nr e s p o n d e n tp r e f e r e n c e ,( 3 )s p e c i f i cf i e l d
notes transcribed from the interview guides and (4) the
interviewer’s initial observation of the interview. In a
process similar to the one described by Knafl et al. [14],
the summaries were descriptive in nature and closely
linked to the respondents’ comments, since the intent
was to express their interpretations of the questionnaire
items. The cognitive interview summary provided a con-
densed description of the overall interview and was a
quick reference for the researchers.
Cognitive interviews were reviewed using transcript-
based analysis. Information from the interview tran-
scripts was aggregated to examine common themes.
Documented information included a basic demographic
summary, question-by-question results and overall com-
ments. Results were then reviewed in several debriefing
meetings to extrapolate similar themes and document
suggestions that led to retention, deletion or revisions in
the questionnaire. In reviewing the responses, four pro-
blem types similar to those discussed by Willis [27]
emerged:
(1) Comprehension/Communication, which reflects
the encoding process (respondents were not able to
understand the meaning of the question); (2) Recall/
Computational, which refers to the retrieval process
(respondents’ memory extended back not more than
12 months); (3) Bias/Sensitivity, which reflects the judg-
ment process (what the interviewer asked was not what
the respondent understood) and (4) Response Category,
which reflects the response process (the given categories
did not match the answers people normally used).
Additionally, suggestions regarding alternative wording
and phrasing were examined. Cognitive interviews
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utes. Conventional interviews using the same instrument
were from 30 to 60 minutes in duration. Updating the
questionnaire was undertaken using an iterative process.
Suggestions from previous interviews were incorporated
into the questionnaire, with the revised questionnaires
being used in subsequent interviews. Iterations pro-
gressed as shown in Figure 1.
Results
Short Acculturation Scale (SAS)
No changes were made to the SAS. This scale had pre-
viously undergone cognitive debriefing with a similar
subpopulation of predominantly Central and South
American pregnant mothers [26]. The internal reliability
of the SAS remained high in the larger patient sample,
with a Cronbach’s a of 0.93 (Table 2).
Stanford Health Assessment Questionnaire Disability
Index (HAQ-DI)
The HAQ-DI introduced questions related to functional
abilities over the past week. There was a need to clarify
whether respondents could relate to the concepts intro-
duced by the scale. Most respondents were able to verify
understanding concepts that helped ground the underly-
ing ideas being communicated, such as the following:
1) Question: Are you able to reach up and take down
a 5-pound object from just above your head?; 2) Probe:
What to you is “a 5-pound object"?; 3) Response: “Like
a bag of sugar.”
Respondents found the HAQ-DI questions related to
items such as the following were confusing and difficult
to answer: raised toilet seat, devices used for dressing,
built-up or special utensils, long-handled appliances for
reach or jar opener for jars previously opened. One of
the respondents recommended the use of pictures as
visual aids to convey requested items, which successfully
eliminated the confusion in future interviews.
Additionally, cognitive interviewing elucidated that some
assumptions and language usage in the original question-
naires may not have taken each respondent’s environmen-
tal and sociocultural context into consideration. Some
respondents in this study had difficulty relating to con-
cepts such as “yard work” because they lived in an apart-
ment. However, during the cognitive debriefing, they were
able to provide their own interpretation of the question
and offer alternatives to verify that they understood the
underlying question. Interviews further suggested that the
HAQ-DI was not sensitive to those respondents in this
sample who lived alone or who had never used a car.
Wong-Baker Faces Pain Scale
To explore patients’ interpretation of the Wong-Baker
Faces Pain Scale, examples of prepared verbal probes
recommended by Willis [13] included the following:
1) What does the term pain mean to you?; 2) What
does no pain mean to you?; 3)What do you think of
when you think of the worst pain?; 4) Pain question: If 0
is “no pain” and 10 is “the worst pain possible,” what is
your pain level now?
Baseline 
Questionnaire























Figure 1 Iterative process.
Table 2 Cronbach’s a for scales
a
Scale Number of items Cronbach’s a (n = 109)




a HAQ-DI Health Assessment Questionnaire Disability Index; SAS, Short
Acculturation Scale; CES-D, Center for Epidemiologic Studies Depression Scale;
ASES, Arthritis Self-Efficacy Scale.
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Wong-Baker Faces Pain Scale were not clear in that the
respondents did not understand that they were to point
to a face with the corresponding word descriptors.
Thus, the original directions were clarified to include
the instruction, “Point to each face using the words to
describe the pain intensity.”
Arthritis Self-Efficacy Scale (ASES)
The ASES contains eight questions designed to measure
the confidence that individuals have in performing spe-
cific arthritis self-management activities [16,18]. Respon-
dents were instructed to select one number between 1
and 10, with 1 being very uncertain and 10 being very
certain, that corresponded best to their level of certainty
that they could perform the self-management activities
listed.
For some of the respondents, assigning a numerical
value to the level of certainty was difficult to compre-
hend. Because of the extensive previous testing of this
instrument in both English and Spanish, a decision was
made to include the scale without further modifications;
however, interviewers did provide respondents with
laminated copies of the instrument during the interview
so that they would have visual cues with numerical
anchors to assist them in selecting their responses. The
internal reliability of the ASES remained acceptable in
the larger patient sample with a Cronbach’s a of 0.87
(Table 2).
Center for Epidemiologic Studies of Depression Scale
(CES-D)
The CES-D questions dealt with feelings during the past
week. Statements were read about a feeling such as
being happy or lonely, and respondents replied how
often they felt that way. Responses indicated that the
questions were on track for the concepts measured. For
example, the following was a typical exchange:
1) Question: “What does the term ‘blues’ mean to
you?"; 2) Response: “Feeling bad/miserable.”
Response categories ranged from 0 to 3 as follows:
rarely or none of the time (<1 day per week), sometimes
or a little of the time (1-2 days per week), occasionally
or a moderate amount of the time (3-4 days per week)
or most or all of the time (5-7 days per week). Respon-
dents experienced difficulty associating the range of 0 to
3 with the number of days in the past week that they
had experienced a specific feeling. One respondent sta-
ted that when he said “1,” he meant less than 1 day or
0. Feedback suggested that participants had to increase
their level of concentration to answer these questions.
The decision was made to create laminated cards with
the response categories to assist response recall among
the participants.
Similar results described by Gonzalez et al.[ 1 6 ]
regarding the question, “Did you feel you were just as
good as other people?” emerged. One participant viewed
this question as a value judgment. Gonzalez et al. [16]
suspected that the English expression is idiomatic and
reflects the notion of self-worth and that a negative
score indicates low self-esteem, while in Spanish a nega-
tive response could be a culturally appropriate avoidance
of bragging about oneself. The decision was made to
continue to include this item, since only one respondent
found it difficult to interpret. The internal reliability of
the CES-D remained high in the larger patient sample,
with a Cronbach’s a of 0.91 (Table 2).
Inventory of Complementary and Alternative Medicine
Practices (ICAMP)
The ICAMP underwent the most significant changes on
the basis of participant feedback. The original ICAMP
section of the questionnaire (see Figure 2) was for-
matted to capture various modalities and time frames:
ever, currently and continuing. Respondents found the
format to be confusing and difficult to answer. The for-
mat was condensed to a yes-or-no leader question
regarding only current use. Respondents who replied yes
were provided a list of modalities related to the subject
at hand (see Figure 3). Making these changes simplified
the previously detailed instructions.
Over 37 verbal probes were added to the CAM section
to determine whether the respondents were familiar
with the type of CAM being discussed. First, there was a
list of prepared probes after each section to test the
familiarity with the various CAM modalities listed, such
as, “What does ‘acupuncturist’ mean to you? Describe in
your own words.” Additional probes were formulated to
elicit more specific information, such as the following:
1) Is it hard to answer how long (in months) you have
ever seen any of these individuals?; 2) Is it easy or diffi-
cult to remember whether you have used these vitamins
or minerals for your arthritis or joint symptoms?;
3) How do you remember each of these?; 4) How sure are
you of your answers?; 5) Is it hard to answer how long you
have ever seen one of these individuals?; 6) What things
do you need to remember to answer whether you have
used these vitamins or minerals?; 7) Are there any other
vitamins or minerals that we haven’tt a l k e da b o u t ?
Cognitive interview feedback suggested that the first
question immediately following the CAM section, “Have
you ever used or are you using any of the strategies men-
tioned in this booklet to specifically help with your arthri-
tis or joint symptoms?” was redundant and thus was
removed from the questionnaire. After several initial inter-
views, concepts such as cost were clarified by asking,
“How much money do you spend per month on thera-
pists, supplements including vitamins, minerals and herbs,
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tion was asked to verbally emphasize that the respondent
should not include prescription medications; however, the
change was not written into the questionnaire.
In the last section of the ICAMP, estrategias que
hemos mencionado (alternative medicine) was not easily
understood by several of the respondents, who did not
understand that this term did not include prescriptions.
When asked for suggested terminology, Spanish-speak-
ing participants felt that using the term medicinas case-
ras to describe CAM was more understandable than the
original wording. After the change was made, the
remaining respondents acknowledged their comprehen-
sion of the revised term medicinas caseras.
Throughout the interviews, as questionnaire-specific
recall periods changed and new questions and concepts
were raised, respondents had difficulty thinking in terms
of limited time frames and had to continually be reor-
iented to the time requested for the specific question
being answered. Many tended to think in terms of the
entire history of their disease process, not in terms of
days, weeks or months.
Participants’ suggestions for improving the overall
questionnaire included providing visual aids, rephrasing
ll. a. Have you EVER
used this supplement 
for your arthritis or joint 
symptoms?
b. Are you CURRENTLY using 
this supplement for your arthritis 
or joint symptoms? If yes, for how 
long?
c. Do you plan to 
CONTINUE to use this 
supplement for your 
arthritis or joint 
symptoms?
Devil’s claw  No  Yes No  Yes
_____ (number of months)
 No  Yes
Eucalyptus   No  Yes  No  Yes
_____ (number of months)
 No  Yes
Fish oil and/or 
omega-3 fatty acids
 No  Yes  No  Yes
_____ (number of months)
 No  Yes
Flaxseed oil  No Yes No  Yes
_____ (number of months)
 No  Yes
Garlic  No  Yes  No  Yes
_____ (number of months)
 No  Yes
Gelatin or Certo in 
grape juice
 No  Yes No  Yes
_____ (number of months)
 No  Yes
Ginger  No  Yes  No  Yes
_____ (number of months)
 No  Yes
Glucosamine  No  Yes  No  Yes
_____ (number of months)
 No  Yes
Entry Question
1. Have you ever used herbs, mixtures, or other supplements that are taken by mouth specifically for your 
arthritis or joint symptoms?  If you aren’t sure, look ahead to the list below and then come back to this 
question.
 No       Please turn to the purple section, Rubs, Lotions, Liniments, Creams and Oils, on page 
9 to continue the booklet.
 Yes     Please answer the questions below about supplements you may take by mouth.
SUPPLEMENTS
Figure 2 Original Inventory of Complementary and Alternative Medicine Practices.
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revising nonapplicable questions and increasing the use
of racially and ethnically concordant interviewers. Speci-
fically, participants explained that questions about pain,
depression and suffering would be more emotionally dif-
ficult to answer, depending on when during their overall
health and treatment continuum the questions were
asked.
Discussion
In this study, we used a cognitive interviewing metho-
dology to understand how the respondents were inter-
preting the questions as well as their comprehension
and recall strategies for evaluating specific outcome
measures. The results from this study in Central and
South Americans and African Americans with rheumatic
disease build on the foundation of work by Lorig and
colleagues [16,18], who have extensively explored the
impact of health behaviors, health status and health care
utilization on arthritis self-management programs in
predominantly Mexican American, Spanish-speaking
communities.
While many cognitive interviews have been conducted
in laboratory facilities, our cognitive interviews were
conducted in the field at a local urban health clinic. Our
face-to-face interviews were conducted in English or in
Spanish using bilingual and bicultural interviewers. In a
previous study conducted in this community, commu-
nity leaders emphasized the importance of establishing
trust within the community as well as with the partici-
pants. Community leaders felt that researchers should
strive for research teams that include individuals from
4b. If yes, what herbs, mixtures, or other supplements that are taken by mouth are you currently using 
specifically for your arthritis or joint symptoms?
 1.   Aloe Vera or Aloe Vera juice
2.   Apple cider vinegar, cranberry juice and honey (or vinegar) or any other similar special drink mixture
3.   Borage oil, black current oil or evening primrose oil
4.   Boron
5.   Boswellia, guggel
6.   Bovine cartilage
7.   Bromelain
8.   Cat’s claw
9.   Cayenne
10. Chondroitin




15. Fish oil and/or omega-3 fatty acids
16. Flaxseed oil
17. Garlic
18. Gelatin or Certo in grape juice
19. Ginger
20. Glucosamine
4a. Are you currently using herbs, mixtures, or other supplements that are taken by mouth specifically for 
your arthritis or joint symptoms?  If you aren’t sure, look ahead to the list below and then come back 
to this question.
 No
 Yes      (if yes, specify below)
SUPPLEMENTS
Figure 3 Final Inventory of Complementary and Alternative Medicine Practices.
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grounds as the participants and who are familiar with
community customs and values [28]. We found that the
use of bilingual and bicultural interviewers strengthened
our study early on by facilitating rapport with the
patients. One English-speaking patient interviewed, who
self-identified as Black, went into great detail about the
importance of language and culture and the need to
have “people that look like me” conducting the inter-
views. Additionally, having bilingual and bicultural inter-
viewers enhanced our interviewing process because the
methodology for cognitive interviews requires the devel-
opment of spontaneous probes depending on the
respondents’ answers to the prepared probes during the
course of the interview.
The results of the cognitive interviewing in this sam-
ple suggest that respondents understand the majority of
the items and that the outcome measures selected are
appropriate for use in similar urban, racial and ethnic
populations with rheumatic disease. Further study of the
performance properties of the instruments, including
reliability, validity and responsiveness, is warranted.
When administering the HAQ-DI, using visual aids for
unfamiliar terms is advised to enhance patients’ under-
standing and ability to respond. While the ICAMP was
significantly modified and proved to be an acceptable
CAM assessment measure in this population, its gener-
alizability for clinical application in other settings is
unclear. Further modifications and psychometric testing
are warranted to test the utility and applicability of
using the ICAMP in diverse clinical inpatient and ambu-
latory settings.
Conclusions
As technology continues to advance, resulting in more
precise diagnoses and earlier and more powerful treat-
ments, patients’ beliefs and behaviors with regard to
health care will likely influence their experience of
health [29]. Measuring population-specific PROs
through reliable and valid measures with particular
attention to item improvement will provide researchers
and clinicians with a broader and more accurate evalua-
tion of health [30]. At a time when comparative effec-
tiveness research and the generation and synthesis of
evidence are of global importance [31], using the same
outcome measures in practice and in clinical trials will
be advantageous for both patient management and
knowledge translation [3].
Cognitive interviewing techniques are useful in a
diverse sample of racial and ethnic minority patients
with rheumatic disease as a method to assess the con-
tent validity of the specific outcome measures selected.
The data collection approaches and methods described
here ultimately enhance data quality. Vigilance is
required in the selection of outcome measures in studies
or in practice, particularly with each new language
translation and/or culturally unique or diverse sample
population.
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